What is the CVR number of Inmedic Group ApS?

Inmedic Group ApS is registered with CVR / Virk under CVR 40711171.

What is the revenue of Inmedic Group ApS?

Inmedic Group ApS reported revenue of DKK 106K in 2024.

Who is the CEO of Inmedic Group ApS?

Henrik Lund Uth is Management of Inmedic Group ApS, in role since 2019.

Where is Inmedic Group ApS headquartered?

Inmedic Group ApS's registered address is Andkærvej 17.

Inmedic Group ApS

APSActive

CVR 40711171Andkærvej 17Manufacture of basic pharmaceutical products · NACE 2110Est. 2019— employees

Full Risika report

Revenue 2024

DKK 106K

-81% vs 2023

EBITDA margin

100.0%

-81% vs 2023

Equity ratio

97.8%

Financial strength

Net profit 2024

DKK 442K

+21% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK 106K	-81%
EBITDA	DKK 106K	-81%
Net profit	DKK 442K	+21%
Total assets	DKK 1,6M	+31%
Equity	DKK 1,6M	+39%
Employees	—	—

Item	2020	2021	2022	2023	2024
Revenue	585	-156	514	562	106
Staff expenses	-0	-0	-0	-0	-0
EBITDA	585	-156	514	562	106
Depreciation & amort.	-0	-0	-0	-125	-150
EBIT	585	-156	514	437	-44
Net financials	-2	-4	-3	-0	477
Profit before tax	583	-161	512	437	433
Tax	128	6	78	73	-9
Net profit	455	-166	433	364	442

Item	2020	2021	2022	2023	2024
Total assets	701	331	912	1.223	1.603
Equity	495	328	762	1.126	1.567
Long-term debt	128	0	78	2	0
Short-term debt	78	3	72	42	3
Total debt	206	3	151	45	3

Name	Role	Member since	Age	Other directorships
HL Henrik Lund Uth Management	Management	2019	—	—

Shareholder	Type	Ownership	Votes	Since
HEMAR ApS	Company	33.3%	33.3%	2019
DAM-ANDERSEN ApS	Company	33.3%	33.3%	2019
Schejbel Holding ApS	Company	33.3%	33.3%	2019

Person	Role here	Other companies
Henrik Lund Uth	Management	0 companies

Inmedic Group ApS

APSActive

CVR 40711171Andkærvej 17Manufacture of basic pharmaceutical products · NACE 2110Est. 2019— employees

Full Risika report

Revenue 2024

DKK 106K

-81% vs 2023

EBITDA margin

100.0%

-81% vs 2023

Equity ratio

97.8%

Financial strength

Net profit 2024

DKK 442K

+21% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK 106K	-81%
EBITDA	DKK 106K	-81%
Net profit	DKK 442K	+21%
Total assets	DKK 1,6M	+31%
Equity	DKK 1,6M	+39%
Employees	—	—